|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600125210 |
|
最近更新日期: Date of Last Refreshed on: |
2026-05-22 11:25:30 |
|
注册时间: Date of Registration: |
2026-05-22 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
不同盆底按摩频率治疗盆底疼痛的效果对比研究 |
|
Public title: |
Comparison of Different Frequencies of Manual Release for Myofascial Pelvic Pain |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
不同盆底肌筋膜手法松解频率对盆底肌筋膜疼痛综合征治疗效果的回顾性对比研究 |
|
Scientific title: |
A Retrospective Comparative Study on the Therapeutic Effects of Different Frequencies of Pelvic Floor Myofascial Release on Myofascial Pelvic Pain Syndrome |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
魏长娜 |
研究负责人: |
魏长娜 |
|
Applicant: |
Wei Changna |
Study leader: |
Wei Changna |
|
申请注册联系人电话: Applicant telephone: |
+86 18267382732 |
研究负责人电话:
Study leader's |
+86 18267382732 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
544631360@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
544631360@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
浙江省嘉兴市南湖区中环东路2468号 |
研究负责人通讯地址: |
浙江省嘉兴市南湖区中环东路2468号 |
|
Applicant address: |
No.2468, Zhonghuan East Road, Nanhu District, Jiaxing City, Zhejiang Province, China |
Study leader's address: |
No.2468, Zhonghuan East Road, Nanhu District, Jiaxing City, Zhejiang Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
嘉兴市妇幼保健院 |
||
|
Applicant's institution: |
Jiaxing Maternity and Child Health Care Hospital |
||
|
研究负责人所在单位: |
嘉兴市妇幼保健院 |
||
|
Affiliation of the Leader: |
Jiaxing Maternity and Child Health Care Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2026-Y-066 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
嘉兴市妇幼保健院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Jiaxing Maternal and Child Health Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-05-09 00:00:00 | ||
|
伦理委员会联系人: |
章园兰 |
||
|
Contact Name of the ethic committee: |
Zhang Yuanlan |
||
|
伦理委员会联系地址: |
浙江省嘉兴市中环东路2468号 |
||
|
Contact Address of the ethic committee: |
No.2468, Zhonghuan East Road, Nanhu District, Jiaxing City, Zhejiang Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 573 83963131 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
13736471268@139.com |
|
研究实施负责(组长)单位: |
嘉兴市妇幼保健院 |
||||||||||||||||||||||
|
Primary sponsor: |
Jiaxing Maternity and Child Health Care Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
浙江省嘉兴市中环东路2468号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.2468, Zhonghuan East Road, Nanhu District, Jiaxing City, Zhejiang Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
嘉兴市妇幼保健院 |
||||||||||||||||||||||
|
Source(s) of funding: |
Jiaxing Maternity and Child Health Care Hospital |
||||||||||||||||||||||
|
研究疾病: |
盆底肌筋膜疼痛综合征 |
||||||||||||||||||||||
|
Target disease: |
Myofascial Pelvic Pain Syndrome (MPPS) |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
对比高频(2-3次/周)与低频(<2次/周)盆底肌筋膜手法松解联合辅助治疗对MPPS患者的临床疗效差异;分析手法频率与疼痛缓解、盆底肌功能改善的相关性;明确最优治疗频率,为临床规范化治疗提供循证依据 。 |
||||||||||||||||||||||
|
Objectives of Study: |
To compare the clinical efficacy of high-frequency (2-3 times/week) versus low-frequency (<2 times/week) pelvic floor myofascial release combined with auxiliary therapy in patients with MPPS; to analyze the correlation between treatment frequency and pain relief as well as muscle function improvement; and to identify the optimal treatment frequency to provide evidence-based support for standardized clinical treatment. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.符合盆底肌筋膜疼痛综合征(MPPS)诊断标准,具有以下临床特征:区域性疼痛:以外阴、阴道、直肠等深部钝痛、胀痛或刺痛为主 ; 功能相关性症状群:合并下尿路症状(尿频、尿急等)、肠道功能障碍或性交痛 ; 特异性体征:体格检查可触及肌筋膜触发点 。 2.2021年4月至2025年12月期间在本院确诊并接受治疗的患者 。 3.年龄18-60岁,病程 > 3个月 。 4.接受全程规范的手法松解治疗(周期 ≥4周),频率明确为一周2-3次或一周2次以下 。 5.同步接受统一的联合辅助治疗(电刺激、生物反馈及居家训练),依从性良好 。 6.临床资料完整,相关记录缺失率 ≤ 10% 。 7.无严重系统性疾病或精神疾病,能配合完成评估 。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Meet the diagnostic criteria for myofascial pelvic pain syndrome (MPPS) with the following clinical features: Regional pain: mainly deep dull pain, distending pain or stabbing pain in the vulva, vagina, rectum, etc. Function - related symptom clusters: combined with lower urinary tract symptoms (such as frequent urination, urgency, etc.), bowel dysfunction or dyspareunia. Specific signs: myofascial trigger points can be palpated during physical examination. 2. Patients diagnosed and treated in our hospital from April 2021 to December 2025. 3. Aged 18 - 60 years old, with a disease duration of more than 3 months. 4. Receive a full - course standardized manual release treatment (treatment cycle >= 4 weeks), with a clear frequency of 2 - 3 times a week or less than 2 times a week. 5. Simultaneously receive unified combined adjuvant therapy (electrical stimulation, biofeedback and home - based training) with good compliance. 6. Have complete clinical data, with a missing rate of relevant records <= 10%. 7. Have no severe systemic diseases or mental diseases and be able to cooperate in completing the assessment. |
||||||||||||||||||||||
|
排除标准: |
1.合并盆腔器质性病变(如子宫肌瘤、内异症)、泌尿系统、肛肠疾病或腰骶关节疾病,影响疼痛评估 。 2.治疗依从性差,未按医嘱完成对应频率治疗,或擅自中断/更改方案 。 3.合并严重心、肝、肾、内分泌等系统性疾病,或精神疾病,无法配合评估 。 4.临床资料缺失较多(缺失率 > 10%),无法完成数据提取及分析 。 5.未完成治疗后随访,无法获取完整疗效或复发信息 。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Co - existing pelvic organic diseases (such as uterine fibroids, endometriosis), urinary system diseases, anorectal diseases or lumbosacral joint diseases that affect pain assessment. 2. Poor treatment compliance, failure to complete the corresponding frequency of treatment as prescribed, or unauthorized interruption/change of the treatment plan. 3. Co - existing severe systemic diseases of the heart, liver, kidneys, endocrine system, etc., or mental diseases, and unable to cooperate with the assessment. 4. A large amount of clinical data is missing (missing rate > 10%), and data extraction and analysis cannot be completed. 5. Failure to complete the follow - up after treatment, and unable to obtain complete information on treatment efficacy or recurrence. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-05-25 00:00:00至 To 2026-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-05-25 00:00:00 至 To 2026-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
通过电子邮件联系主要研究者(PI)申请获取脱敏后的个体参与者数据。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Contact the principal investigator (PI) via email to apply for de - identified individual participant data. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
采集流程:由专人从本院电子病历、检验系统及盆底康复系统提取目标数据 。 录入与核对:使用 Excel 模板录入,并由另一名研究人员进行二次核对,确保数据真实准确 。 匿名化处理:所有提取的数据均进行编号匿名化处理,剔除受试者姓名、身份证号等身份识别信息,严格保护隐私 。 存储安全:数据存储于专用科研电脑,实行权限管理,严禁向无关人员泄露 。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Collection process: Designated personnel extract target data from the hospital's electronic medical records, laboratory systems, and pelvic - floor rehabilitation systems. Input and verification: Use an Excel template for input, and have another researcher conduct a second - check to ensure the authenticity and accuracy of the data. Anonymization: All extracted data are numbered and anonymized, and identity - identifying information such as the names and ID numbers of participants is removed to strictly protect privacy. Storage security: Data are stored on dedicated research computers, with access rights management, and unauthorized personnel are prohibited from disclosing the data. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |